Literature DB >> 18388875

Mice as clinically relevant models for the study of cytochrome P450-dependent metabolism.

S Muruganandan1, C J Sinal.   

Abstract

The cytochrome P450 (CYP) gene superfamily comprises a large group of hemoproteins with diverse functions in steroid, lipid, and xenobiotic metabolism. The human genome is estimated to contain 57 genes that encode functional CYP proteins, a number of which are important for the metabolism of foreign chemicals, including carcinogens and most therapeutic drugs. Given that metabolic interactions are a major source of adverse drug interactions, a comprehensive understanding of CYP function is critically important for the development and safe clinical application of drugs. While some cross-species genetic conservation of CYPs exists, drug metabolism can differ between humans and other mammalian species. The development of humanized mice that replicate many aspects of human drug metabolism has provided invaluable experimental models that circumvent this limitation to a considerable degree. This brief review focuses on the value and limitations of mouse models for the study of drug metabolism in humans.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18388875     DOI: 10.1038/clpt.2008.50

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


  22 in total

Review 1.  Experimental approaches for defining functional roles of microbes in the human gut.

Authors:  Gautam Dantas; Morten O A Sommer; Patrick H Degnan; Andrew L Goodman
Journal:  Annu Rev Microbiol       Date:  2013       Impact factor: 15.500

2.  Special issue on source water risk control. Preface.

Authors:  Shupei Cheng; Tim Ford
Journal:  Ecotoxicology       Date:  2009-06-07       Impact factor: 2.823

3.  Preclinical models for interrogating drug action in human cancers using Stable Isotope Resolved Metabolomics (SIRM).

Authors:  Andrew N Lane; Richard M Higashi; Teresa W-M Fan
Journal:  Metabolomics       Date:  2016-06-29       Impact factor: 4.290

4.  RNA sequencing reveals dynamic changes of mRNA abundance of cytochromes P450 and their alternative transcripts during mouse liver development.

Authors:  Lai Peng; Byunggil Yoo; Sumedha S Gunewardena; Hong Lu; Curtis D Klaassen; Xiao-Bo Zhong
Journal:  Drug Metab Dispos       Date:  2012-03-20       Impact factor: 3.922

5.  Adverse Geriatric Outcomes Secondary to Polypharmacy in a Mouse Model: The Influence of Aging.

Authors:  Aniko Huizer-Pajkos; Alice E Kane; Susan E Howlett; John Mach; Sarah J Mitchell; Rafael de Cabo; David G Le Couteur; Sarah N Hilmer
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2015-05-04       Impact factor: 6.053

Review 6.  Methods to study mechanisms underlying altered hepatic drug elimination during pregnancy.

Authors:  Hyunyoung Jeong; Catherine S Stika
Journal:  Semin Perinatol       Date:  2020-01-25       Impact factor: 3.300

Review 7.  Drug-metabolizing enzyme, transporter, and nuclear receptor genetically modified mouse models.

Authors:  Xi-Ling Jiang; Frank J Gonzalez; Ai-Ming Yu
Journal:  Drug Metab Rev       Date:  2010-09-21       Impact factor: 4.518

Review 8.  Humanized mouse lines and their application for prediction of human drug metabolism and toxicological risk assessment.

Authors:  Connie Cheung; Frank J Gonzalez
Journal:  J Pharmacol Exp Ther       Date:  2008-08-05       Impact factor: 4.030

9.  Generation of a Humanized Mouse Liver Using Human Hepatic Stem Cells.

Authors:  Ran-Ran Zhang; Yun-Wen Zheng; Hideki Taniguchi
Journal:  J Vis Exp       Date:  2016-08-29       Impact factor: 1.355

10.  Effect of prototypical inducers on ligand activated nuclear receptor regulated drug disposition genes in rodent hepatic and intestinal cells.

Authors:  Philip Martin; Robert Riley; Paul Thompson; Dominic Williams; David Back; Andrew Owen
Journal:  Acta Pharmacol Sin       Date:  2010-01       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.